these differences are illustrated in the preparation and use of 186re ( sn ) -hedp and 99mtc ( sn ) -hedp diphosphonate radiopharmaceuticals designed , respectively , for palliative therapy and diagnosis of metastatic cancer to bone , and in the preparation and biodistribution of tr [ 186re ( dmpe ) 2cl2 ] + and [ 186re ( dmpe ) 3 ] + , analogs to the potential myocardial perfusion imaging agents tr- [ 99mtc ( dmpe ) 2cl2 ] + and [ 99mtc ( dmpe ) 3 ] + .
C0086268
hedp
C0012544
diphosphonate